President, Chief Executive Officer & Co-Founder, BioCardia
Appears in 1 story
Leading FDA approval effort
For two decades, scientists have known how to grow cells and engineer genes that could repair damaged hearts. The problem has been getting those therapies to the right spot. On February 10, 2026, BioCardia filed for FDA approval of the Helix catheter—a device that threads through blood vessels to inject treatments directly into heart muscle. If approved, it would be the first system of its kind cleared for use in the United States.
Updated Feb 10
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
